Octreotide protects against LPS-induced endothelial cell and lung injury
Cellular Signalling · 2024
DOI: 10.1016/j.cellsig.2024.111455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2024. Verfasst von Saikat Fakir und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA. Hauptthemen laut MEDLINE: Lipopolysaccharides, Octreotide, Endothelial Cells, Acute Lung Injury. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, National Institutes of Health.
Abstract (Originalsprache)
Growth hormone (GH) is a crucial regulator of growth, cell reproduction, and regeneration; and it is controlled by growth hormone-releasing hormone (GHRH) and somatostatin. Lipopolysaccharides (LPS) can compromise endothelial function, leading to increased inflammation and vascular leak. Octreotide (OCT) is an FDA-approved synthetic somatostatin analog (SSA) used to treat acromegaly and neuroendocrine tumors. The present study investigates the effects of OCT on LPS-induced injury in bovine and human lung endothelial cells, as well as in mouse lungs. Our in vitro observations suggest that OCT effectively counteracts LPS-induced endothelial leak, inflammation, and reactive oxygen species (ROS) generation. Furthermore, OCT reduces bronchoalveolar lavage fluid (BALF) protein concentration in an experimental model of Acute Lung Injury (ALI). Our study suggests that OCT mitigates LPS-induced endothelial cell and lung injury, suggesting that it may represent an exciting therapeutic possibility in diseases related to barrier dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA.
- School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA. Electronic address: barabutis@ulm.edu.
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
Zitieren
APA
Fakir, S., Kubra, K. T., & Barabutis, N. (2024). Octreotide protects against LPS-induced endothelial cell and lung injury. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2024.111455
Vancouver
Fakir S, Kubra KT, Barabutis N. Octreotide protects against LPS-induced endothelial cell and lung injury. Cellular Signalling. 2024. doi:10.1016/j.cellsig.2024.111455
BibTeX
@article{Fakir2024,
author = {Fakir, Saikat and Kubra, Khadeja-Tul and Barabutis, Nektarios},
title = {Octreotide protects against LPS-induced endothelial cell and lung injury},
journal = {Cellular Signalling},
year = {2024},
doi = {10.1016/j.cellsig.2024.111455}
}
EUVIMED